173 related articles for article (PubMed ID: 26681053)
21. Survivin protein as predictor of pathologic response in patients with locally advanced cervical cancer treated with chemoradiation followed by radical surgery.
Zannoni GF; Petrillo M; Vellone VG; Martinelli E; Chiarello G; Ferrandina G; Scambia G
Hum Pathol; 2014 Sep; 45(9):1872-8. PubMed ID: 24997647
[TBL] [Abstract][Full Text] [Related]
22. [Relationship between the levels of KAI1/CD82 and CD44 and the clinicopathological features of non-small cell lung cancer].
Chen QY; Lin XM; Zhou JY; An Z; Yang L; Jiang ZY
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Feb; 27(2):101-4. PubMed ID: 14990184
[TBL] [Abstract][Full Text] [Related]
23. KAI1/CD82 expression as a prognosic factor in sporadic colorectal cancer.
Muneyuki T; Watanabe M; Yamanaka M; Shiraishi T; Isaji S
Anticancer Res; 2001; 21(5):3581-7. PubMed ID: 11848527
[TBL] [Abstract][Full Text] [Related]
24. Expression of survivin in CIN and invasive squamous cell carcinoma of uterine cervix.
Kim HS; Shiraki K; Park SH
Anticancer Res; 2002; 22(2A):805-8. PubMed ID: 12014654
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of KAI1/CD82 in human melanoma and its role in cell migration and invasion through the regulation of ING4.
Tang Y; Cheng Y; Martinka M; Ong CJ; Li G
Carcinogenesis; 2014 Jan; 35(1):86-95. PubMed ID: 24130172
[TBL] [Abstract][Full Text] [Related]
26. [Expressions of Snail, Slug and KAI1 proteins in cervical carcinoma and their clinicopathological significance].
Gong X; Tao Y; Zhou L; Yu L; Wu S; Song W; Wang D; Cheng Z
Nan Fang Yi Ke Da Xue Xue Bao; 2015 Dec; 35(12):1733-8. PubMed ID: 26714907
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathological significance of PI3K, Akt and survivin expression in gastric cancer.
Gu Y; Jin S; Wang F; Hua Y; Yang L; Shu Y; Zhang Z; Guo R
Biomed Pharmacother; 2014 May; 68(4):471-5. PubMed ID: 24726064
[TBL] [Abstract][Full Text] [Related]
28. Inhibitors of apoptosis proteins in human cervical cancer.
Espinosa M; Cantú D; Herrera N; Lopez CM; De la Garza JG; Maldonado V; Melendez-Zajgla J
BMC Cancer; 2006 Feb; 6():45. PubMed ID: 16504151
[TBL] [Abstract][Full Text] [Related]
29. [Expression and clinical value of KAI1/CD82 in carcinoma of larynx].
Shu Y; Chen H; Tan Y
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Dec; 19(23):1065-7. PubMed ID: 16494006
[TBL] [Abstract][Full Text] [Related]
30. High expressions of bcl-2 and survivin, and decreased apoptosis in uterine cervical carcinosarcoma compared to cervical squamous cell carcinoma.
Gan XL; Li JK; Yu TH; Zhang Y; Hu LN
Arch Gynecol Obstet; 2011 Jul; 284(1):175-81. PubMed ID: 20668868
[TBL] [Abstract][Full Text] [Related]
31. [Role of KAI1 gene expression and loss of heterozygosity of KAI1 in metastatic potential and prognosis of pancreatic cancer].
Fan LX; Shen L; Li JY; Pan KF; Dong B; Zhang Y
Zhonghua Bing Li Xue Za Zhi; 2009 Jan; 38(1):42-6. PubMed ID: 19489224
[TBL] [Abstract][Full Text] [Related]
32. Expression of survivin, CD117, and C-erbB-2 in neuroendocrine carcinoma of the uterine cervix.
Sukpan K; Settakorn J; Khunamornpong S; Cheewakriangkrai C; Srisomboon J; Siriaunkgul S
Int J Gynecol Cancer; 2011 Jul; 21(5):911-7. PubMed ID: 21633298
[TBL] [Abstract][Full Text] [Related]
33. Expression Levels of Tetraspanin KAI1/CD82 in Breast Cancers in North Indian Females.
Singh R; Bhatt ML; Singh SP; Kumar V; Goel MM; Mishra DP; Srivastava K; Kumar R
Asian Pac J Cancer Prev; 2016; 17(7):3431-6. PubMed ID: 27509988
[TBL] [Abstract][Full Text] [Related]
34. P16INK4A and survivin: Diagnostic and prognostic markers in cervical intraepithelial neoplasia and cervical squamous cell carcinoma.
Liu HQ; Wang YH; Wang LL; Hao M
Exp Mol Pathol; 2015 Aug; 99(1):44-9. PubMed ID: 25910412
[TBL] [Abstract][Full Text] [Related]
35. KAI1 metastasis suppressor gene is frequently down-regulated in cervical carcinoma.
Liu FS; Chen JT; Dong JT; Hsieh YT; Lin AJ; Ho ES; Hung MJ; Lu CH
Am J Pathol; 2001 Nov; 159(5):1629-34. PubMed ID: 11696423
[TBL] [Abstract][Full Text] [Related]
36. [Expression of KAI1/CD82 in neuroblastoma and its correlation to prognosis].
Wu XR; Zhu MH; Zhang ZD
Ai Zheng; 2005 Jul; 24(7):885-9. PubMed ID: 16004821
[TBL] [Abstract][Full Text] [Related]
37. [Expression of survivin and its correlation with p53 and bcl-2 expression in laryngeal and hypopharyngeal cancer].
Sun M; Qin Y
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Apr; 22(8):346-8, 351. PubMed ID: 18595518
[TBL] [Abstract][Full Text] [Related]
38. Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer.
Adachi M; Taki T; Ieki Y; Huang CL; Higashiyama M; Miyake M
Cancer Res; 1996 Apr; 56(8):1751-5. PubMed ID: 8620488
[TBL] [Abstract][Full Text] [Related]
39. Frequent loss of KAI1 expression in squamous and lymphoid neoplasms. An immunohistochemical study of archival tissues.
Geradts J; Maynard R; Birrer MJ; Hendricks D; Abbondanzo SL; Fong KM; Barrett JC; Lombardi DP
Am J Pathol; 1999 Jun; 154(6):1665-71. PubMed ID: 10362791
[TBL] [Abstract][Full Text] [Related]
40. Hypoxia inducible factor-1α-mediated activation of survivin in cervical cancer cells.
Bai H; Ge S; Lu J; Qian G; Xu R
J Obstet Gynaecol Res; 2013 Feb; 39(2):555-63. PubMed ID: 22925504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
